Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.66 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.76.
Market Cap
9.66T
Revenue
4.66T
Profits
186.64B
PE Ratio
51.76
Profit Margin
4.00%
Dividend Yield
0.37%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.14T | 4.46% | 4,541,763 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 658.89B | 0.85% | 7,728,511 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 470.00B | 2.72% | 5,535,972 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 375.50B | 12.60% | 32,776,268 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 348.81B | -1.35% | 5,268,510 | 450.53B |
| 6 | NVS | Novartis AG | 301.65B | 3.73% | 2,400,551 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 254.32B | 3.03% | 3,817,874 | 61.37B |
| 8 | AMGN | Amgen Inc. | 239.15B | 4.02% | 2,543,982 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 226.85B | 4.16% | 2,507,286 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 206.57B | 1.68% | 19,511,353 | 50.34B |
| 11 | ABT | Abbott Laboratories | 198.01B | 1.55% | 7,403,621 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 183.02B | 2.90% | 6,738,817 | 30.46B |
| 13 | PFE | Pfizer Inc. | 160.96B | 3.63% | 59,804,172 | 63.70B |
| 14 | DHR | Danaher Corporation | 148.68B | 5.97% | 5,253,020 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 140.51B | 1.67% | 2,125,170 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 139.93B | 4.52% | 1,437,714 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 138.11B | 2.36% | 13,889,244 | 49.19B |
| 18 | SYK | Stryker Corporation | 130.41B | 2.60% | 2,188,067 | 25.84B |
| 19 | MDT | Medtronic plc | 120.48B | 2.22% | 5,636,476 | 36.36B |
| 20 | CVS | CVS Health Corporation | 119.78B | -1.33% | 6,351,620 | 412.65B |
| 21 | SNY | Sanofi | 109.72B | 1.91% | 2,741,187 | 55.89B |
| 22 | GSK | GSK plc | 104.47B | 3.38% | 3,902,449 | 44.05B |
| 23 | MCK | McKesson Corporation | 99.53B | -1.79% | 938,782 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 88.13B | -1.14% | 1,436,621 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.41B | 0.05% | 1,123,085 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 83.96B | 3.78% | 750,446 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 75.37B | 3.05% | 16,834,155 | 21.00B |
| 28 | CI | The Cigna Group | 73.31B | -0.38% | 1,126,053 | 282.38B |
| 29 | MRNA | Moderna, Inc. | 69.62B | 176.97% | 199,252,329 | 2.23B |
| 30 | ARGX | argenx SE | 63.98B | 4.02% | 390,893 | 5.32B |
| 31 | COR | Cencora, Inc. | 60.51B | 0.31% | 1,175,849 | 332.77B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.12B | 1.61% | 3,309,734 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 54.62B | -0.06% | 1,375,022 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 53.19B | 1.43% | 3,406,151 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.10B | 3.78% | 2,164,453 | 22.48B |
| 36 | NTRA | Natera, Inc. | 46.86B | 4.29% | 1,792,089 | 2.71B |
| 37 | RVMD | Revolution Medicines, Inc. | 46.01B | -0.62% | 1,308,104 | - |
| 38 | HUM | Humana Inc. | 45.39B | -1.04% | 1,141,349 | 145.68B |
| 39 | MDLN | Medline Inc. | 44.58B | -0.62% | 7,800,098 | 29.94B |
| 40 | IDXX | IDEXX Laboratories, Inc. | 44.29B | 1.60% | 453,652 | 4.55B |
| 41 | A | Agilent Technologies, Inc. | 43.89B | 4.70% | 3,006,248 | 7.23B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 43.66B | 2.43% | 7,975,799 | 17.32B |
| 43 | HLN | Haleon plc | 42.90B | 1.54% | 11,622,374 | 14.80B |
| 44 | ONC | BeOne Medicines AG | 42.85B | 2.09% | 379,901 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 41.03B | 3.85% | 1,209,505 | 16.98B |
| 46 | WAT | Waters Corporation | 40.86B | 3.64% | 1,091,780 | 4.64B |
| 47 | VEEV | Veeva Systems Inc. | 40.77B | 3.40% | 1,800,385 | 3.32B |
| 48 | ALC | Alcon Inc. | 35.84B | 0.97% | 1,652,640 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.49B | 3.42% | 3,256,562 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 33.92B | 0.31% | 8,668,161 | 4.97B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 33.70B | 2.74% | 2,942,333 | 21.27B |
| 52 | RMD | ResMed Inc. | 33.27B | 4.85% | 1,209,808 | 5.65B |
| 53 | BIIB | Biogen Inc. | 32.74B | 4.24% | 886,915 | 10.03B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.46B | 6.12% | 1,879,216 | 4.80B |
| 55 | CNC | Centene Corporation | 31.96B | -0.80% | 2,879,972 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 31.69B | 3.68% | 5,222,006 | 9.53B |
| 57 | ILMN | Illumina, Inc. | 30.96B | 8.87% | 2,090,866 | 4.49B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.55B | 1.82% | 121,745 | 4.13B |
| 59 | INSM | Insmed Incorporated | 28.53B | 1.71% | 1,493,674 | 1.14B |
| 60 | BNTX | BioNTech SE | 28.42B | 21.96% | 8,780,348 | 3.03B |
| 61 | ROIV | Roivant Sciences Ltd. | 27.01B | 0.08% | 5,814,897 | 7.53M |
| 62 | PHG | Koninklijke Philips N.V. | 26.88B | 1.92% | 827,447 | 20.18B |
| 63 | LH | Labcorp Holdings Inc. | 26.80B | 2.56% | 518,287 | 14.35B |
| 64 | DGX | Quest Diagnostics Incorporated | 26.68B | 2.33% | 924,013 | 11.56B |
| 65 | INCY | Incyte Corporation | 26.04B | 4.05% | 1,589,005 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.83B | 1.79% | 511,064 | 3.33B |
| 67 | STE | STERIS plc | 23.10B | 1.95% | 706,449 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.70B | 2.10% | 432,111 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 21.92B | 2.01% | 2,386,674 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.62B | -0.63% | 704,137 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.04B | 3.49% | 3,229,221 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.21B | 1.60% | 1,501,880 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.66B | 0.46% | 5,677,006 | 14.74B |
| 74 | ASND | Ascendis Pharma A/S | 17.05B | 4.33% | 541,222 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.98B | 3.04% | 169,054 | 2.78B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.41B | 1.17% | 3,285,282 | 713.07M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.37B | -0.36% | 549,516 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.81B | 0.85% | 1,162,825 | 3.37B |
| 79 | COO | The Cooper Companies, Inc. | 14.96B | 1.28% | 1,383,954 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.95B | 0.41% | 917,870 | 8.31B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.84B | 3.87% | 987,465 | 4.00B |
| 82 | BAX | Baxter International Inc. | 13.77B | 2.70% | 5,053,983 | 11.47B |
| 83 | EXEL | Exelixis, Inc. | 13.48B | 2.39% | 2,503,641 | 2.44B |
| 84 | BMRN | BioMarin Pharmaceutical Inc. | 13.42B | 3.49% | 1,977,464 | 3.41B |
| 85 | RVTY | Revvity, Inc. | 13.33B | 5.01% | 1,718,081 | 2.91B |
| 86 | ICLR | ICON Public Limited Company | 13.31B | 3.26% | 687,879 | 8.29B |
| 87 | PEN | Penumbra, Inc. | 12.87B | 0.64% | 305,256 | 1.50B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.87B | 0.78% | 859,697 | 830.81M |
| 89 | FMS | Fresenius Medical Care AG | 12.65B | 1.19% | 506,459 | 22.19B |
| 90 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.63B | 1.72% | 1,363,715 | 669.50M |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.48B | 3.01% | 221,135 | 1.28B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 12.36B | -0.29% | 2,907,577 | 14.37B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.24B | 3.64% | 3,973,985 | 5.02B |
| 94 | SNN | Smith & Nephew plc | 12.23B | -2.91% | 1,857,666 | 6.30B |
| 95 | HALO | Halozyme Therapeutics, Inc. | 12.21B | 2.60% | 2,539,548 | 1.66B |
| 96 | EHC | Encompass Health Corporation | 12.01B | -0.29% | 825,637 | 6.21B |
| 97 | GMED | Globus Medical, Inc. | 11.86B | 2.20% | 1,063,953 | 3.14B |
| 98 | ALGN | Align Technology, Inc. | 11.58B | -2.90% | 928,987 | 4.14B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.43B | 1.16% | 572,115 | 776.57M |
| 100 | DVA | DaVita Inc. | 11.30B | -0.36% | 413,980 | 14.01B |
| 101 | TECH | Bio-Techne Corporation | 11.29B | 0.36% | 2,513,910 | 1.22B |
| 102 | GKOS | Glaukos Corporation | 11.18B | 2.93% | 505,427 | 612.84M |
| 103 | TEM | Tempus AI, Inc. | 11.05B | 24.09% | 22,543,631 | 1.43B |
| 104 | CYTK | Cytokinetics, Incorporated | 10.81B | 2.16% | 1,505,965 | 67.67M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 10.78B | 4.42% | 421,798 | 7.46M |
| 106 | KYMR | Kymera Therapeutics, Inc. | 10.59B | 4.89% | 842,927 | 105.00M |
| 107 | ENSG | The Ensign Group, Inc. | 10.55B | - | 206,764 | 5.49B |
| 108 | PODD | Insulet Corporation | 10.51B | 2.35% | 1,311,497 | 3.05B |
| 109 | MOH | Molina Healthcare, Inc. | 10.48B | -1.20% | 461,651 | 42.47B |
| 110 | SMMT | Summit Therapeutics Inc. | 10.46B | 2.26% | 5,431,233 | - |
| 111 | ABVX | ABIVAX Société Anonyme | 10.38B | 1.36% | 637,080 | 5.67M |
| 112 | RDY | Dr. Reddy's Laboratories Limited | 10.21B | -0.33% | 3,263,319 | 3.50B |
| 113 | KRYS | Krystal Biotech, Inc. | 10.16B | 3.16% | 162,843 | 440.48M |
| 114 | APGE | Apogee Therapeutics, Inc. | 10.16B | 0.10% | 1,417,489 | - |
| 115 | UHS | Universal Health Services, Inc. | 10.16B | -0.44% | 821,297 | 18.11B |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 10.10B | 1.98% | 3,137,561 | 874.09M |
| 117 | PTGX | Protagonist Therapeutics, Inc. | 10.03B | -1.53% | 786,053 | 281.99M |
| 118 | OSCR | Oscar Health, Inc. | 9.96B | 3.26% | 3,874,439 | 15.32B |
| 119 | RGEN | Repligen Corporation | 9.95B | 6.15% | 1,898,690 | 785.10M |
| 120 | HSIC | Henry Schein, Inc. | 9.95B | 0.07% | 1,177,290 | 13.60B |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 9.74B | 3.28% | 257,994 | 2.59B |
| 122 | SYRE | Spyre Therapeutics, Inc. | 9.60B | 1.02% | 1,166,127 | - |
| 123 | AVTR | Avantor, Inc. | 9.44B | 4.73% | 6,421,212 | 6.56B |
| 124 | PCVX | Vaxcyte, Inc. | 9.42B | 5.87% | 1,444,926 | - |
| 125 | IMVT | Immunovant, Inc. | 9.29B | 1.49% | 1,273,522 | - |
| 126 | QGEN | Qiagen N.V. | 9.20B | 5.15% | 4,809,759 | 2.10B |
| 127 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | -0.04% | 2,141,443 | 42.16M |
| 128 | BRKR | Bruker Corporation | 8.94B | 3.15% | 1,913,825 | 3.50B |
| 129 | TWST | Twist Bioscience Corporation | 8.93B | 22.64% | 3,548,866 | 431.80M |
| 130 | HQY | HealthEquity, Inc. | 8.69B | 1.13% | 678,674 | 1.34B |
| 131 | IBRX | ImmunityBio, Inc. | 8.62B | 5.31% | 13,063,683 | 165.79M |
| 132 | ATR | AptarGroup, Inc. | 8.45B | 0.91% | 390,416 | 3.93B |
| 133 | ALKS | Alkermes plc | 8.42B | 1.41% | 1,544,220 | 1.67B |
| 134 | TXG | 10x Genomics, Inc. | 8.10B | 11.79% | 3,909,933 | 616.91M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.97B | 0.42% | 669,895 | 239.92M |
| 136 | TGTX | TG Therapeutics, Inc. | 7.33B | 2.85% | 1,289,535 | 799.54M |
| 137 | ORKA | Oruka Therapeutics, Inc. | 7.26B | -3.00% | 1,302,924 | - |
| 138 | HIMS | Hims & Hers Health, Inc. | 7.25B | 13.51% | 20,013,469 | 2.58B |
| 139 | CGON | CG Oncology, Inc. | 7.15B | 5.75% | 845,883 | 6.23M |
| 140 | HNGE | Hinge Health, Inc. | 7.14B | 0.25% | 1,472,394 | 720.06M |
| 141 | GRFS | Grifols, S.A. | 7.11B | 6.45% | 926,386 | 8.48B |
| 142 | PACS | PACS Group, Inc. | 7.01B | 1.05% | 680,758 | 5.55B |
| 143 | CHE | Chemed Corporation | 6.97B | 1.22% | 131,247 | 2.60B |
| 144 | SRRK | Scholar Rock Holding Corporation | 6.88B | 3.27% | 1,326,269 | - |
| 145 | BLTE | Belite Bio, Inc | 6.79B | 3.68% | 126,092 | - |
| 146 | LQDA | Liquidia Corporation | 6.74B | 1.35% | 1,156,450 | 450.91M |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.64B | 1.36% | 556,271 | 618.07M |
| 148 | LNTH | Lantheus Holdings, Inc. | 6.56B | 0.22% | 1,254,365 | 1.56B |
| 149 | CAI | Caris Life Sciences, Inc. | 6.43B | 8.54% | 6,559,223 | 989.61M |
| 150 | COGT | Cogent Biosciences, Inc. | 6.40B | -1.47% | 1,249,799 | - |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 6.36B | -1.59% | 793,272 | 1.90M |
| 152 | ERAS | Erasca, Inc. | 6.32B | -0.17% | 3,311,944 | - |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.30B | 1.65% | 872,288 | 840.85M |
| 154 | BLCO | Bausch + Lomb Corporation | 6.23B | 2.41% | 537,946 | 5.32B |
| 155 | TVTX | Travere Therapeutics, Inc. | 6.22B | 3.22% | 1,522,024 | 591.33M |
| 156 | DFTX | Definium Therapeutics, Inc. | 6.16B | -0.78% | 1,747,954 | - |
| 157 | PTCT | PTC Therapeutics, Inc. | 6.15B | 1.43% | 1,514,568 | 1.01B |
| 158 | XENE | Xenon Pharmaceuticals Inc. | 6.04B | -1.36% | 558,957 | 7.50M |
| 159 | RDNT | RadNet, Inc. | 5.94B | 2.32% | 371,913 | 2.27B |
| 160 | STVN | Stevanato Group S.p.A. | 5.93B | 2.41% | 463,637 | 1.40B |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 5.80B | 1.08% | 231,199 | 290.54M |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 5.78B | -0.44% | 1,469,873 | 3.12B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.78B | 12.91% | 3,843,326 | 13.39M |
| 164 | TFX | Teleflex Incorporated | 5.76B | 2.99% | 459,648 | 2.25B |
| 165 | MMED | MiniMed Group, Inc. | 5.68B | 4.44% | 1,619,385 | 3.10B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.49B | 3.05% | 694,124 | 1.58B |
| 167 | SHC | Sotera Health Company | 5.42B | 2.65% | 2,683,338 | 1.22B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.21B | 0.10% | 2,288,068 | 1.14B |
| 169 | PBLS | Parabilis Medicines, Inc. | 5.10B | 5.01% | 425,141 | 148.00K |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 5.04B | 5.28% | 2,237,449 | - |
| 171 | DYN | Dyne Therapeutics, Inc. | 5.00B | 3.00% | 1,952,108 | - |
| 172 | HAE | Haemonetics Corporation | 4.93B | 3.59% | 1,460,333 | 1.35B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.90B | 3.80% | 2,637,656 | 1.58B |
| 174 | WAY | Waystar Holding Corp. | 4.76B | 2.14% | 1,511,707 | 1.21B |
| 175 | ICUI | ICU Medical, Inc. | 4.68B | 1.90% | 235,039 | 2.16B |
| 176 | MANE | Veradermics, Incorporated | 4.65B | -0.07% | 748,362 | - |
| 177 | INDV | Indivior Pharmaceuticals, Inc. | 4.61B | -0.99% | 2,476,877 | 1.33B |
| 178 | DOCS | Doximity, Inc. | 4.59B | 3.25% | 4,902,109 | 655.57M |
| 179 | CELC | Celcuity Inc. | 4.58B | 0.44% | 591,541 | - |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.54B | 0.63% | 2,101,614 | 10.35M |
| 181 | LIVN | LivaNova PLC | 4.45B | 1.23% | 496,649 | 1.47B |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 4.43B | -0.80% | 964,109 | 2.29B |
| 183 | NVST | Envista Holdings Corporation | 4.43B | -0.86% | 3,214,248 | 2.86B |
| 184 | LEGN | Legend Biotech Corporation | 4.37B | 3.10% | 2,639,854 | 1.27B |
| 185 | ELVN | Enliven Therapeutics, Inc. | 4.35B | -1.13% | 939,740 | - |
| 186 | BLLN | BillionToOne, Inc. | 4.33B | 4.18% | 529,951 | 397.41M |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.30B | 9.94% | 8,262,303 | -665.00K |
| 188 | ITGR | Integer Holdings Corporation | 4.26B | 0.17% | 657,965 | 1.84B |
| 189 | TNGX | Tango Therapeutics, Inc. | 4.25B | -0.94% | 1,823,758 | 53.81M |
| 190 | VKTX | Viking Therapeutics, Inc. | 4.20B | 7.82% | 2,686,216 | - |
| 191 | IRTC | iRhythm Holdings, Inc. | 4.11B | 8.25% | 609,543 | 825.34M |
| 192 | DNLI | Denali Therapeutics Inc. | 4.11B | 5.68% | 1,150,287 | 3.60M |
| 193 | TLX | Telix Pharmaceuticals Limited | 4.07B | 2.02% | 88,729 | 890.79M |
| 194 | ADPT | Adaptive Biotechnologies Corporation | 4.07B | 3.79% | 2,145,838 | 308.08M |
| 195 | HTFL | HeartFlow, Inc. | 3.96B | 0.66% | 2,941,097 | 212.07M |
| 196 | ABCL | AbCellera Biologics Inc. | 3.89B | 8.00% | 10,808,540 | 66.17M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.86B | 2.85% | 1,816,243 | 117.00M |
| 198 | GPCR | Structure Therapeutics Inc. | 3.86B | 1.12% | 710,056 | - |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | 2.48% | 931,924 | 234.13M |
| 200 | NHC | National HealthCare Corporation | 3.67B | -0.06% | 101,789 | 1.56B |
| 201 | IOVA | Iovance Biotherapeutics, Inc. | 3.62B | 13.66% | 24,248,268 | 324.97M |
| 202 | OGN | Organon & Co. | 3.61B | 0.37% | 3,314,288 | 6.13B |
| 203 | WRBY | Warby Parker Inc. | 3.52B | 11.28% | 2,633,985 | 911.61M |
| 204 | OPCH | Option Care Health, Inc. | 3.50B | -0.26% | 1,943,295 | 5.69B |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.41B | 4.70% | 1,032,236 | 7.12M |
| 206 | VCYT | Veracyte, Inc. | 3.39B | 3.71% | 1,761,839 | 561.90M |
| 207 | IMNM | Immunome, Inc. | 3.39B | 8.22% | 2,984,904 | 4.02M |
| 208 | QURE | uniQure N.V. | 3.38B | 2.91% | 1,281,963 | 18.67M |
| 209 | PLSE | Pulse Biosciences, Inc. | 3.35B | 2.22% | 420,892 | 1.19M |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | -0.30% | 1,025,411 | 463.98M |
| 211 | GRAL | GRAIL, Inc. | 3.30B | 4.33% | 1,098,200 | 165.26M |
| 212 | MBX | MBX Biosciences, Inc. | 3.29B | 2.83% | 562,345 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.27B | -0.22% | 1,392,384 | 158.00K |
| 214 | TMDX | TransMedics Group, Inc. | 3.26B | 3.62% | 703,325 | 668.47M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | 3.39% | 757,496 | 606.33M |
| 216 | ALMS | Alumis Inc. | 3.11B | -3.58% | 937,935 | 7.40M |
| 217 | IRON | Disc Medicine, Inc. | 3.08B | 0.15% | 457,246 | - |
| 218 | ZLAB | Zai Lab Limited | 3.00B | 4.50% | 1,729,451 | 449.61M |
| 219 | BEAM | Beam Therapeutics Inc. | 2.90B | 9.41% | 3,111,283 | 156.04M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.89B | -0.82% | 3,456,911 | 2.93B |
| 221 | NRIX | Nurix Therapeutics, Inc. | 2.88B | 3.19% | 2,101,970 | 36.77M |
| 222 | RGC | Regencell Bioscience Holdings Limited | 2.88B | 6.41% | 256,922 | - |
| 223 | AVAH | Aveanna Healthcare Holdings Inc. | 2.87B | 3.87% | 2,481,008 | 2.60B |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.82B | -1.00% | 797,224 | 830.44M |
| 225 | VRDN | Viridian Therapeutics, Inc. | 2.81B | 3.64% | 1,833,775 | 71.13M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.80B | 5.73% | 9,123,108 | - |
| 227 | PRVA | Privia Health Group, Inc. | 2.75B | -0.14% | 852,337 | 2.36B |
| 228 | ATAI | AtaiBeckley Inc. | 2.73B | 0.96% | 9,140,260 | 4.47M |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.68B | -0.16% | 1,977,446 | - |
| 230 | ALHC | Alignment Healthcare, Inc. | 2.65B | -3.40% | 3,993,211 | 4.58B |
| 231 | NEOG | Neogen Corporation | 2.65B | 5.01% | 2,055,783 | 870.40M |
| 232 | AXGN | Axogen, Inc. | 2.63B | -2.51% | 982,909 | 251.17M |
| 233 | NKTR | Nektar Therapeutics | 2.60B | 3.31% | 731,781 | 54.59M |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | 2.94% | 2,846,577 | 717.00M |
| 235 | BHC | Bausch Health Companies Inc. | 2.58B | -0.58% | 2,503,397 | 10.85B |
| 236 | OCUL | Ocular Therapeutix, Inc. | 2.58B | 6.54% | 3,024,296 | 52.06M |
| 237 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.57B | 3.81% | 2,906,762 | 940.61M |
| 238 | PGEN | Precigen, Inc. | 2.56B | 6.07% | 8,152,572 | 85.72M |
| 239 | NUVB | Nuvation Bio Inc. | 2.55B | 4.31% | 11,552,379 | 169.90M |
| 240 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | -0.36% | 2,244,228 | 3.37B |
| 241 | PHVS | Pharvaris N.V. | 2.55B | 0.47% | 1,042,116 | - |
| 242 | KOD | Kodiak Sciences Inc. | 2.51B | -1.43% | 595,817 | - |
| 243 | ALMR | Alamar Biosciences, Inc. | 2.47B | 7.83% | 555,835 | 100.42M |
| 244 | URGN | UroGen Pharma Ltd. | 2.46B | 2.80% | 2,389,406 | 188.73M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.45B | 2.19% | 382,690 | 1.10B |
| 246 | BFLY | Butterfly Network, Inc. | 2.44B | 1.89% | 3,835,461 | 112.14M |
| 247 | UFPT | UFP Technologies, Inc. | 2.42B | -0.37% | 101,595 | 631.64M |
| 248 | ATRC | AtriCure, Inc. | 2.42B | 4.04% | 928,812 | 569.62M |
| 249 | COAG | Hemab Therapeutics Holdings, Inc. | 2.41B | -1.49% | 279,909 | - |
| 250 | CDNA | CareDx, Inc. | 2.41B | 0.71% | 1,887,577 | 458.09M |
| 251 | GRDN | Guardian Pharmacy Services, Inc. | 2.41B | -0.81% | 230,678 | 1.46B |
| 252 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 1.28% | 1,222,092 | - |
| 253 | WGS | GeneDx Holdings Corp. | 2.38B | 4.34% | 672,858 | 454.43M |
| 254 | KLRA | Kailera Therapeutics, Inc. | 2.38B | 2.75% | 2,077,577 | - |
| 255 | RAPP | Rapport Therapeutics, Inc. | 2.35B | 0.12% | 232,316 | 20.00M |
| 256 | VERA | Vera Therapeutics, Inc. | 2.33B | -0.02% | 1,259,823 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.33B | 2.83% | 765,793 | 959.90M |
| 258 | NBTX | Nanobiotix S.A. | 2.25B | 10.49% | 131,921 | 38.27M |
| 259 | ADMA | ADMA Biologics, Inc. | 2.25B | 5.35% | 2,688,986 | 512.28M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.25B | 0.19% | 246,543 | 245.82M |
| 261 | CLOV | Clover Health Investments, Corp. | 2.24B | -0.24% | 2,883,525 | 2.48B |
| 262 | VCEL | Vericel Corporation | 2.23B | -1.56% | 630,188 | 306.30M |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | -0.72% | 3,855,816 | 3.64B |
| 264 | ADUS | Addus HomeCare Corporation | 2.20B | 1.60% | 193,621 | 1.48B |
| 265 | MESO | Mesoblast Limited | 2.19B | 2.76% | 132,456 | 65.38M |
| 266 | GENB | Generate Biomedicines, Inc. | 2.18B | 5.53% | 1,390,393 | 26.48M |
| 267 | HCM | HUTCHMED (China) Limited | 2.16B | -0.40% | 50,654 | 549.12M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.31% | 217,206 | - |
| 269 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | 5.69% | 1,646,454 | 311.51M |
| 270 | NEO | NeoGenomics, Inc. | 2.14B | 4.75% | 1,561,879 | 766.30M |
| 271 | BHVN | Biohaven Ltd. | 2.14B | 4.20% | 1,963,568 | - |
| 272 | STOK | Stoke Therapeutics, Inc. | 2.13B | 2.77% | 1,472,256 | 27.59M |
| 273 | NVCR | NovoCure Limited | 2.12B | 5.57% | 4,838,625 | 699.19M |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 2.10B | 2.09% | 1,690,407 | 98.34M |
| 275 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 3.88% | 4,280,345 | 5.49M |
| 276 | SRPT | Sarepta Therapeutics, Inc. | 2.08B | 9.49% | 4,943,337 | 1.97B |
| 277 | MD | Pediatrix Medical Group, Inc. | 2.08B | -1.28% | 1,354,111 | 1.95B |
| 278 | KARD | Kardigan, Inc. | 2.06B | 5.21% | 213,506 | - |
| 279 | SEPN | Septerna, Inc. | 2.05B | 0.30% | 383,524 | 98.88M |
| 280 | XNCR | Xencor, Inc. | 2.05B | 8.30% | 2,351,122 | 104.97M |
| 281 | GHRS | GH Research PLC | 2.05B | 0.20% | 357,356 | - |
| 282 | ZBIO | Zenas BioPharma, Inc. | 2.04B | -2.07% | 2,702,744 | 1.00M |
| 283 | ASTH | Astrana Health, Inc. | 2.02B | 0.61% | 384,496 | 3.84B |
| 284 | DMRA | Damora Therapeutics, Inc. | 2.00B | 2.01% | 486,698 | - |
| 285 | PGNY | Progyny, Inc. | 1.96B | -0.70% | 867,405 | 1.31B |
| 286 | LKFT | Lakefront Biotherapeutics NV | 1.95B | 4.89% | 316,091 | 1.13B |
| 287 | TRLV | Trulieve Cannabis Corp. | 1.94B | 4.13% | 1,474,707 | 1.14B |
| 288 | CMPS | COMPASS Pathways plc | 1.94B | 0.79% | 2,836,065 | - |
| 289 | PRGO | Perrigo Company plc | 1.94B | 7.63% | 2,571,940 | 4.14B |
| 290 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 6,480,149 | - |
| 291 | ZYME | Zymeworks Inc. | 1.93B | 4.37% | 845,210 | 37.13M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.92B | 0.27% | 419,841 | 481.07M |
| 293 | LMAT | LeMaitre Vascular, Inc. | 1.92B | 2.88% | 252,041 | 262.43M |
| 294 | IMCR | Immunocore Holdings plc | 1.90B | 2.33% | 677,778 | 430.78M |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | 13.27% | 30,369,727 | 54.86M |
| 296 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | 25.78% | 15,140,362 | 208.78M |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.86B | 14.48% | 6,114,892 | 59.51M |
| 298 | BRVE | Braveheart Bio, Inc. | 1.86B | 8.30% | 391,831 | - |
| 299 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 4.27% | 1,186,647 | 252.25M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.78B | 4.38% | 703,136 | 106.69M |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.78B | 7.51% | 578,126 | 898.74M |
| 302 | SGRY | Surgery Partners, Inc. | 1.76B | -4.49% | 2,090,441 | 3.37B |
| 303 | ETON | Eton Pharmaceuticals, Inc. | 1.76B | -3.07% | 608,921 | 105.60M |
| 304 | ANAB | AnaptysBio, Inc. | 1.75B | 0.46% | 258,753 | 232.39M |
| 305 | AVLN | Avalyn Pharma Inc. | 1.73B | 0.28% | 141,730 | - |
| 306 | FTRE | Fortrea Holdings Inc. | 1.73B | 3.07% | 1,034,058 | 2.68B |
| 307 | ABSI | Absci Corporation | 1.71B | 12.88% | 4,530,095 | 1.56M |
| 308 | BCAX | Bicara Therapeutics Inc. | 1.71B | 3.77% | 670,444 | - |
| 309 | PSNL | Personalis, Inc. | 1.69B | 13.66% | 8,279,947 | 69.67M |
| 310 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | 1.50% | 245,132 | 978.38M |
| 311 | OMCL | Omnicell, Inc. | 1.66B | 1.28% | 667,427 | 1.25B |
| 312 | VIR | Vir Biotechnology, Inc. | 1.65B | 2.95% | 2,085,738 | 303.23M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.65B | 2.13% | 358,721 | 20.00M |
| 314 | KMTS | Kestra Medical Technologies, Ltd. | 1.64B | -0.07% | 237,656 | 95.13M |
| 315 | TNDM | Tandem Diabetes Care, Inc. | 1.63B | -1.14% | 1,655,414 | 1.04B |
| 316 | TRAX | First Tracks Biotherapeutics, Inc. | 1.63B | 3.69% | 810,495 | - |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.60B | -0.79% | 2,250,054 | 335.41M |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.60B | 2.96% | 303,632 | - |
| 319 | LBRX | LB Pharmaceuticals Inc | 1.58B | 0.35% | 162,253 | - |
| 320 | AAPG | Ascentage Pharma Group International | 1.58B | -0.93% | 23,124 | 94.61M |
| 321 | HCSG | Healthcare Services Group, Inc. | 1.57B | 4.51% | 1,064,754 | 1.86B |
| 322 | AGL | agilon health, inc. | 1.57B | -1.84% | 268,761 | 5.92B |
| 323 | HROW | Harrow, Inc. | 1.56B | 5.36% | 651,737 | 275.59M |
| 324 | AZTA | Azenta, Inc. | 1.56B | 8.00% | 839,912 | 613.81M |
| 325 | INVA | Innoviva, Inc. | 1.55B | 1.08% | 505,513 | 440.00M |
| 326 | FRNM | Freenome, Inc. | 1.54B | 1.34% | 840,132 | 34.24M |
| 327 | CNMD | CONMED Corporation | 1.54B | 4.04% | 366,794 | 1.37B |
| 328 | ENOV | Enovis Corporation | 1.53B | 3.35% | 748,364 | 2.30B |
| 329 | SLBT | SL Science Holding Limited | 1.52B | -1.84% | 18,582 | 3.27M |
| 330 | ORIC | ORIC Pharmaceuticals, Inc. | 1.52B | 5.24% | 1,393,028 | - |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.51B | 2.31% | 1,544,998 | 815.05M |
| 332 | OMDA | Omada Health, Inc. | 1.50B | 3.03% | 1,800,011 | 309.76M |
| 333 | ARDT | Ardent Health, Inc. | 1.50B | -2.84% | 369,620 | 6.41B |
| 334 | INBX | Inhibrx Biosciences, Inc. | 1.49B | 7.25% | 310,658 | 1.30M |
| 335 | INNV | InnovAge Holding Corp. | 1.48B | -1.44% | 158,036 | 949.17M |
| 336 | SDGR | Schrödinger, Inc. | 1.48B | 12.34% | 1,898,074 | 259.04M |
| 337 | AVBP | ArriVent BioPharma, Inc. | 1.48B | 0.07% | 522,882 | - |
| 338 | NVAX | Novavax, Inc. | 1.45B | 10.84% | 11,451,113 | 413.80M |
| 339 | CGEM | Cullinan Therapeutics, Inc. | 1.45B | 8.06% | 707,193 | - |
| 340 | MGTX | MeiraGTx Holdings plc | 1.44B | 7.78% | 1,096,995 | 397.50M |
| 341 | PAHC | Phibro Animal Health Corporation | 1.44B | 2.28% | 163,097 | 1.50B |
| 342 | JBIO | Jade Biosciences, Inc. | 1.43B | -4.25% | 789,061 | - |
| 343 | MLTX | MoonLake Immunotherapeutics | 1.42B | 2.45% | 1,448,058 | - |
| 344 | ALVO | Alvotech | 1.42B | 1.01% | 546,895 | 562.04M |
| 345 | SVRA | Savara Inc. | 1.42B | 3.91% | 1,298,221 | - |
| 346 | MNKD | MannKind Corporation | 1.41B | 7.99% | 5,435,478 | 393.63M |
| 347 | AORT | Artivion, Inc. | 1.41B | -0.28% | 679,117 | 471.47M |
| 348 | REPL | Replimune Group, Inc. | 1.40B | -4.94% | 3,441,405 | - |
| 349 | VOR | Vor Biopharma Inc. | 1.40B | 1.29% | 1,041,456 | - |
| 350 | AKTS | Aktis Oncology, Inc. | 1.39B | 0.08% | 216,573 | 10.06M |
| 351 | ANRO | Alto Neuroscience, Inc. | 1.37B | 2.23% | 335,729 | - |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.37B | 2.26% | 619,815 | 3.43B |
| 353 | PNTG | The Pennant Group, Inc. | 1.37B | -0.66% | 217,420 | 1.10B |
| 354 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | 4.92% | 1,070,234 | 28.73M |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.34B | -1.77% | 652,367 | 1.65B |
| 356 | DRTS | Alpha Tau Medical Ltd. | 1.34B | 1.47% | 651,995 | - |
| 357 | OMER | Omeros Corporation | 1.33B | 6.98% | 3,197,709 | 38.42M |
| 358 | LTGO | Latigo Biotherapeutics, Inc. | 1.32B | 4.70% | 175,592 | - |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 1.88% | 240,946 | - |
| 360 | NUTX | Nutex Health Inc. | 1.31B | 1.58% | 95,537 | 846.72M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | 3.84% | 846,328 | - |
| 362 | APMD | Apnimed, Inc. | 1.28B | 0.69% | 132,635 | 120.15M |
| 363 | CERT | Certara, Inc. | 1.28B | 4.37% | 2,026,419 | 421.75M |
| 364 | IMTX | Immatics N.V. | 1.26B | 1.76% | 593,320 | 47.65M |
| 365 | PRCT | PROCEPT BioRobotics Corporation | 1.25B | 2.77% | 635,988 | 337.34M |
| 366 | STAA | STAAR Surgical Company | 1.24B | 0.08% | 1,022,849 | 339.59M |
| 367 | BVS | Bioventus Inc. | 1.23B | 2.66% | 466,986 | 581.85M |
| 368 | SANA | Sana Biotechnology, Inc. | 1.23B | 12.95% | 5,910,519 | - |
| 369 | TDOC | Teladoc Health, Inc. | 1.21B | 2.94% | 3,226,760 | 2.49B |
| 370 | GDRX | GoodRx Holdings, Inc. | 1.21B | -3.01% | 3,767,367 | 785.23M |
| 371 | CRON | Cronos Group Inc. | 1.21B | 2.49% | 1,375,172 | 179.09M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 1.28% | 147,003 | 804.27M |
| 373 | ODTX | Odyssey Therapeutics, Inc. | 1.16B | 10.48% | 226,161 | 99.00K |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.14B | -1.17% | 624,041 | 1.04B |
| 375 | IVA | Inventiva S.A. | 1.12B | 2.59% | 575,199 | 7.94M |
| 376 | GMRS | GMR Solutions Inc. | 1.12B | 2.20% | 1,540,130 | 5.88B |
| 377 | IRMD | IRADIMED CORPORATION | 1.12B | -0.17% | 100,864 | 86.34M |
| 378 | KURA | Kura Oncology, Inc. | 1.11B | 1.62% | 4,077,719 | 77.23M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.11B | 5.28% | 999,046 | 59.00K |
| 380 | OPK | OPKO Health, Inc. | 1.09B | 7.35% | 3,365,709 | 587.90M |
| 381 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | -0.41% | 1,776,305 | 41.47M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.07B | 3.30% | 914,233 | 24.00M |
| 383 | WVE | Wave Life Sciences, Inc. | 1.07B | 2.36% | 2,837,020 | 65.37M |
| 384 | SLDB | Solid Biosciences Inc. | 1.04B | 7.27% | 1,243,989 | - |
| 385 | ANNX | Annexon, Inc. | 1.04B | 4.17% | 3,504,308 | - |
| 386 | CADL | Candel Therapeutics, Inc. | 1.03B | 12.03% | 2,376,815 | - |
| 387 | GERN | Geron Corporation | 1.02B | 3.92% | 8,015,955 | 204.56M |
| 388 | ARDX | Ardelyx, Inc. | 1.00B | 2.81% | 3,050,143 | 450.89M |
| 389 | DSGN | Design Therapeutics, Inc. | 997.55M | 4.39% | 706,354 | - |
| 390 | CLYM | Climb Bio, Inc. | 995.94M | -0.29% | 1,286,596 | - |
| 391 | OLMA | Olema Pharmaceuticals, Inc. | 989.60M | 6.20% | 1,757,970 | - |
| 392 | CSTL | Castle Biosciences, Inc. | 987.36M | 11.33% | 451,918 | 357.28M |
| 393 | ABUS | Arbutus Biopharma Corporation | 985.28M | 2.89% | 3,428,247 | 181.72M |
| 394 | PCRX | Pacira BioSciences, Inc. | 971.04M | 1.50% | 336,180 | 746.16M |
| 395 | AVR | Anteris Technologies Global Corp. | 958.02M | 2.61% | 1,261,282 | 2.24M |
| 396 | CBLL | CeriBell, Inc. | 955.23M | 2.81% | 845,353 | 101.96M |
| 397 | ATTO | Attovia Therapeutics, Inc. | 952.66M | -4.73% | 364,349 | 1.35M |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 947.96M | 2.06% | 2,065,238 | 8.22M |
| 399 | QDEL | QuidelOrtho Corporation | 946.34M | 2.76% | 1,315,286 | 2.67B |
| 400 | IMMX | Immix Biopharma, Inc. | 943.60M | 11.69% | 1,975,395 | - |
| 401 | COLL | Collegium Pharmaceutical, Inc. | 935.65M | 0.84% | 769,362 | 808.21M |
| 402 | FDMT | 4D Molecular Therapeutics, Inc. | 925.89M | 13.86% | 1,965,153 | 92.01M |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 924.77M | 1.87% | 410,772 | 730.02M |
| 404 | ANL | Adlai Nortye Ltd. | 922.82M | 1.20% | 150,538 | 18.06M |
| 405 | SGP | SpyGlass Pharma, Inc. | 910.79M | 5.38% | 124,139 | - |
| 406 | BBNX | Beta Bionics, Inc. | 900.24M | 5.21% | 1,947,730 | 119.01M |
| 407 | SIBN | SI-BONE, Inc. | 892.34M | 4.02% | 436,391 | 213.60M |
| 408 | TBPH | Theravance Biopharma, Inc. | 882.10M | 0.24% | 257,860 | 104.31M |
| 409 | ACHV | Achieve Life Sciences, Inc. | 877.76M | 13.43% | 3,924,730 | - |
| 410 | DBVT | DBV Technologies S.A. | 877.60M | 2.14% | 263,227 | 5.04M |
| 411 | RIGL | Rigel Pharmaceuticals, Inc. | 877.21M | 7.66% | 515,828 | 276.79M |
| 412 | GLAS | Glass House Brands Inc. | 869.92M | 3.63% | 356,718 | 177.68M |
| 413 | OBX | Obsidian Therapeutics, Inc. | 866.53M | 0.25% | 48,596 | - |
| 414 | INMD | InMode Ltd. | 864.51M | 0.33% | 491,749 | 374.63M |
| 415 | FTH | Faeth Therapeutics, Inc. | 855.58M | 0.33% | 260,547 | - |
| 416 | OCS | Oculis Holding AG | 837.70M | 2.88% | 272,419 | 1.45M |
| 417 | HSTM | HealthStream, Inc. | 834.80M | 0.14% | 229,210 | 321.12M |
| 418 | PHAR | Pharming Group N.V. | 832.13M | -0.50% | 17,233 | 366.48M |
| 419 | MNPR | Monopar Therapeutics Inc. | 831.24M | 4.02% | 400,365 | - |
| 420 | AHG | Akso Health Group | 828.18M | -7.49% | 18,818 | 13.83M |
| 421 | SLN | Silence Therapeutics plc | 819.45M | -3.48% | 977,258 | 615.00K |
| 422 | DRUG | Bright Minds Biosciences Inc. | 814.40M | 0.83% | 116,101 | - |
| 423 | AURA | Aura Biosciences, Inc. | 807.86M | -4.53% | 1,144,451 | - |
| 424 | RGNX | REGENXBIO Inc. | 793.48M | 8.58% | 1,146,911 | 174.48M |
| 425 | NGNE | Neurogene Inc. | 789.05M | 10.54% | 383,100 | 925.00K |
| 426 | VREX | Varex Imaging Corporation | 778.05M | - | 1,254,309 | 865.00M |
| 427 | CTMX | CytomX Therapeutics, Inc. | 777.90M | 5.31% | 4,579,168 | 18.30M |
| 428 | ALLO | Allogene Therapeutics, Inc. | 770.44M | 9.85% | 6,714,918 | 4.64M |
| 429 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 769.67M | 7.26% | 414,325 | - |
| 430 | STTK | Shattuck Labs, Inc. | 768.78M | 2.82% | 767,474 | 1.00M |
| 431 | NVCT | Nuvectis Pharma, Inc. | 760.13M | 11.57% | 362,931 | - |
| 432 | GYRE | Gyre Therapeutics, Inc. | 758.14M | 2.44% | 87,803 | 109.82M |
| 433 | AHCO | AdaptHealth Corp. | 755.10M | -2.75% | 2,664,781 | 3.36B |
| 434 | CBIO | Crescent Biopharma, Inc. | 741.31M | 3.77% | 170,245 | 11.88M |
| 435 | PHAT | Phathom Pharmaceuticals, Inc. | 740.29M | 0.76% | 781,955 | 239.66M |
| 436 | PHR | Phreesia, Inc. | 739.27M | 4.55% | 1,453,977 | 495.59M |
| 437 | HELP | Cybin Inc. | 730.17M | 0.94% | 734,630 | - |
| 438 | TECX | Tectonic Therapeutic, Inc. | 724.11M | 1.17% | 199,974 | - |
| 439 | SSII | SS Innovations International, Inc. | 721.39M | -2.96% | 38,659 | 52.40M |
| 440 | IRWD | Ironwood Pharmaceuticals, Inc. | 720.45M | 1.16% | 1,478,135 | 389.32M |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 720.33M | 4.84% | 1,117,955 | 136.07M |
| 442 | EVO | Evotec SE | 705.36M | 3.66% | 34,908 | 819.47M |
| 443 | SOPH | SOPHiA GENETICS SA | 704.86M | 8.66% | 1,322,752 | 86.17M |
| 444 | KIDS | OrthoPediatrics Corp. | 691.91M | 3.92% | 378,005 | 252.72M |
| 445 | ASMB | Assembly Biosciences, Inc. | 689.00M | 5.32% | 384,565 | 74.85M |
| 446 | STLN | Starling Oncology, Inc. | 678.76M | 4.06% | 1,305,531 | 587.24M |
| 447 | AGMB | AgomAb Therapeutics NV | 677.16M | 0.15% | 137,390 | - |
| 448 | AUTL | Autolus Therapeutics plc | 676.05M | 10.92% | 7,840,758 | 117.39M |
| 449 | ANGO | AngioDynamics, Inc. | 664.21M | 1.58% | 305,503 | 320.17M |
| 450 | CRMD | CorMedix Inc. | 664.09M | 4.28% | 1,467,120 | 462.25M |
| 451 | VSTM | Verastem, Inc. | 660.66M | -1.82% | 2,371,624 | 87.53M |
| 452 | SGMT | Sagimet Biosciences Inc. | 657.64M | - | 1,552,036 | - |
| 453 | TLRY | Tilray Brands, Inc. | 655.02M | 8.05% | 5,615,493 | 915.45M |
| 454 | EIKN | Eikon Therapeutics, Inc. | 650.52M | 3.09% | 1,406,872 | - |
| 455 | MDXG | MiMedx Group, Inc. | 648.63M | 2.53% | 1,159,602 | 355.17M |
| 456 | VALN | Valneva SE | 641.15M | -0.44% | 74,418 | 163.30M |
| 457 | SPRY | ARS Pharmaceuticals, Inc. | 634.47M | 1.27% | 1,212,559 | 116.93M |
| 458 | ARVN | Arvinas, Inc. | 632.94M | 4.54% | 494,207 | 316.70M |
| 459 | PRME | Prime Medicine, Inc. | 629.78M | 16.07% | 6,791,333 | 4.07M |
| 460 | CTKB | Cytek Biosciences, Inc. | 610.92M | 0.64% | 1,038,804 | 206.71M |
| 461 | OABI | OmniAb, Inc. | 609.19M | 6.89% | 2,872,344 | 38.46M |
| 462 | ALT | Altimmune, Inc. | 606.90M | 5.05% | 10,824,069 | 31.00K |
| 463 | BWAY | BrainsWay Ltd. | 604.84M | 3.48% | 71,266 | 60.70M |
| 464 | CTNM | Contineum Therapeutics, Inc. | 602.69M | 10.48% | 545,563 | - |
| 465 | CTEV | Claritev Corporation | 599.77M | -0.59% | 102,073 | 994.67M |
| 466 | PRLD | Prelude Therapeutics Incorporated | 595.31M | 0.52% | 421,548 | 22.42M |
| 467 | DCTH | Delcath Systems, Inc. | 595.08M | 1.72% | 531,086 | 95.42M |
| 468 | SCTX | Scribe Therapeutics Inc. | 585.74M | 14.53% | 412,832 | 36.28M |
| 469 | WEAV | Weave Communications, Inc. | 584.79M | 0.41% | 8,402,078 | 257.79M |
| 470 | AQST | Aquestive Therapeutics, Inc. | 576.10M | 6.25% | 8,415,712 | 54.09M |
| 471 | CERS | Cerus Corporation | 574.35M | 3.26% | 1,604,076 | 221.55M |
| 472 | OVID | Ovid Therapeutics Inc. | 572.22M | 3.17% | 2,875,503 | 1.58M |
| 473 | ARTV | Artiva Biotherapeutics, Inc. | 572.01M | 0.17% | 457,998 | 251.00K |
| 474 | EOLS | Evolus, Inc. | 568.03M | 5.13% | 964,004 | 316.49M |
| 475 | MPLT | MapLight Therapeutics, Inc. | 563.49M | 2.79% | 896,389 | - |
| 476 | ZURA | Zura Bio Limited | 559.64M | 1.21% | 884,796 | - |
| 477 | KYTX | Kyverna Therapeutics, Inc. | 548.55M | 4.35% | 796,719 | - |
| 478 | EVMN | Evommune, Inc. | 544.74M | 5.56% | 293,203 | 10.00M |
| 479 | FLGT | Fulgent Genetics, Inc. | 543.15M | 6.30% | 264,962 | 323.93M |
| 480 | EYPT | EyePoint, Inc. | 543.14M | 15.17% | 8,792,924 | 2.79M |
| 481 | ENTX | Entera Bio Ltd. | 538.47M | 7.61% | 696,062 | 42.00K |
| 482 | TCMD | Tactile Systems Technology, Inc. | 534.59M | -1.05% | 395,075 | 350.31M |
| 483 | CABA | Cabaletta Bio, Inc. | 525.59M | 6.53% | 10,448,708 | - |
| 484 | SRTA | Strata Critical Medical, Inc. | 521.07M | 3.33% | 819,318 | 255.98M |
| 485 | DNA | Ginkgo Bioworks Holdings, Inc. | 519.19M | 18.07% | 2,466,726 | 132.42M |
| 486 | CCCC | C4 Therapeutics, Inc. | 517.94M | 0.72% | 2,848,774 | 35.04M |
| 487 | EVH | Evolent Health, Inc. | 517.81M | - | 2,559,921 | 2.10B |
| 488 | RLMD | Relmada Therapeutics, Inc. | 515.22M | -0.41% | 595,935 | - |
| 489 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 490 | NPCE | NeuroPace, Inc. | 502.51M | 1.17% | 106,611 | 106.99M |
| 491 | OCGN | Ocugen, Inc. | 501.88M | 10.45% | 6,882,661 | 4.58M |
| 492 | EDIT | Editas Medicine, Inc. | 499.14M | 12.85% | 9,641,326 | 47.01M |
| 493 | BLSM | BlossomHill Therapeutics, Inc. | 495.51M | 0.43% | 193,081 | - |
| 494 | BIOA | BioAge Labs, Inc. | 493.39M | 2.77% | 412,251 | 10.36M |
| 495 | RZLT | Rezolute, Inc. | 493.08M | 1.29% | 1,220,243 | - |
| 496 | PBYI | Puma Biotechnology, Inc. | 489.87M | 2.71% | 262,892 | 231.24M |
| 497 | CLPT | ClearPoint Neuro, Inc. | 486.85M | 5.14% | 516,782 | 42.28M |
| 498 | NRC | NRC Health | 486.19M | -0.14% | 104,715 | 140.00M |
| 499 | SI | Shoulder Innovations, Inc. | 484.25M | 10.08% | 228,920 | 60.06M |
| 500 | SENS | Senseonics Holdings, Inc. | 481.68M | 4.83% | 1,020,162 | 48.55M |